Submicroscopic genomic imbalances in burkitt lymphomas/leukemias: Association with age and further evidence that 8q24/MYC translocations are not sufficient for leukemogenesis

Genes Chromosomes and Cancer

Volumn 52, Issue 4, 2013, Pages 370-377

  Lundin, Catarina ^a   Hjorth, Lars ^a   Behrendtz, Mikael ^b   Ehinger, Mats ^a   Biloglav, Andrea ^a   Johansson, Bertil ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; MYC PROTEIN; PROTEIN P53; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F2K; TRANSCRIPTION FACTOR MIRI7HG; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BURKITT LYMPHOMA; CANCER DIAGNOSIS; CANCER PATIENT; CHILD; CHILDHOOD; CHROMOSOME 13Q14.2 Q14.3; CHROMOSOME 1Q23.3 Q31.3; CHROMOSOME 6Q14.1; CHROMOSOME 6Q22.33; CHROMOSOME 7; CHROMOSOME 8Q24 TRANSLOCATION; CHROMOSOME 9P21.3; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME BANDING PATTERN; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GAIN OF FUNCTION MUTATION; GENE DELETION; GENE EXPRESSION; GENE LOSS; GENETIC ASSOCIATION; GENOMIC INSTABILITY; HUMAN; LEUKEMOGENESIS; LOSS OF FUNCTION MUTATION; MALE; MOLECULAR GENETICS; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT DISEASE; SCHOOL CHILD; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; UNIPARENTAL DISOMY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BURKITT LYMPHOMA; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 22; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-MYC; TRANSLOCATION, GENETIC; YOUNG ADULT;

EID: 84873691981     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22034     Document Type: Article

References (58)

1. Adams JM, Harris AW, Pinkert CA, Corcoran LM, Alexander WS, Cory S, Palmiter RD, Brinster RL. 1985. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318: 533-538.
2. Berger R, Bernheim A, Weh HJ, Flandrin G, Daniel MT, Brouet JC, Colbert N. 1979. A new translocation in Burkitt's tumor cells. Hum Genet 53: 111-112.
3. Berger R, Le Coniat M, Derré J, Vecchione D. 1989. Secondary nonrandom chromosomal abnormalities of band 13q34 in Burkitt lymphoma-leukemia. Genes Chromosomes Cancer 1: 115-118.
4. Boerma EG, van Imhoff GW, Appel IM, Veeger NJGM, Kluin PhM, Kluin-Nelemans JC. 2004. Gender and age-related differences in Burkitt lymphoma-Epidemiological and clinical data from The Netherlands. Eur J Cancer 40: 2781-2787.
5. Boerma EG, Siebert R, Kluin PM, Baudis M. 2009. Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: A historical review of cytogenetics in the light of todays knowledge. Leukemia 23: 225-234.
6. Calasanz MJ, Cigudosa JC, Odero MD, Ferreira C, Ardanaz MT, Fraile A, Carrasco JL, Solé F, Cuesta B, Gullón A. 1997. Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: primary breakpoints and clinical correlations. Genes Chromosomes Cancer 18: 84-93.
7. Cheung KJ, Delaney A, Ben-Neriah S, Schein J, Lee T, Shah SP, Cheung D, Johnson NA, Mungall AJ, Telenius A, Lai B, Boyle M, Connors JM, Gascoyne RD, Marra MA, Horsman DE. 2010. High resolution analysis of follicular lymphoma genomes reveals somatic recurrent sites of copy-neutral loss of heterozygosity and copy number alterations that target single genes. Genes Chromosomes Cancer 49: 669-681.
8. Chuang SS, Huang WT, Hsieh PP, Jung YC, Ye H, Du MQ, Lu CL, Cho CY, Hsiao SC, Hsu YH, Lin KJ. 2008. Sporadic paediatric and adult Burkitt lymphomas share similar phenotypic and genotypic features. Histopathology 52: 427-435.
9. Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, Croce CM. 1982. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci U S A 79: 7824-7827.
10. Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma E-J, Greiner TC, Weisenburger DD, Rosenwald A, Ott G, Müller-Hermelink H-K, Gascoyne RD, Delabie J, Rimsza LM, Braziel RM, Grogan TM, Campo E, Jaffe ES, Dave BJ, Sanger W, Bast M, Vose JM, Armitage JO, Connors JM, Smeland EB, Kvaloy S, Holte H, Fisher RI, Miller TP, Montserrat E, Wilson WH, Bahl M, Zhao H, Yang L, Powell J, Simon R, Chan WC, Staudt LM. 2006. Molecular diagnosis of Burkitt's lymphoma. N Engl J Med 354: 2431-2442.
11. Davidsson J, Andersson A, Paulsson K, Heidenblad M, Isaksson M, Borg Å, Heldrup J, Behrendtz M, Panagopoulos I, Fioretos T, Johansson B. 2007. Tiling resolution array comparative genomic hybridization, expression and methylation analyses of dup(1q) in Burkitt lymphomas and pediatric high hyperdiploid acute lymphoblastic leukemias reveal clustered near-centromeric breakpoints and overexpression of genes in 1q22-32.3. Hum Mol Genet 16: 2215-2225.
12. de la Chapelle A, Lenoir G, Boué J, Boué A, Gallano P, Huerre C, Szajnert MF, Jeanpierre M, Lalouel JM, Kaplan JC. 1983. Lambda Ig constant region genes are translocated to chromosome 8 in Burkitt's lymphoma with t(8;22). Nucleic Acids Res 11: 1133-1142.
13. Erikson J, Finan J, Nowell PC, Croce CM. 1982. Translocation of immunoglobulin VH genes in Burkitt lymphoma. Proc Natl Acad Sci U S A 79: 5611-5615.
14. Gaidano G, Ballerini P, Gong JZ, Inghirami G, Neri A, Newcomb EW, Magrath IT, Knowles DM, Dalla-Favera R. 1991. p53 Mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 88: 5413-5417.
15. García JL, Hernandez JM, Gutiérrez NC, Flores T, González D, Calasanz MJ, Martínez-Climent JA, Piris MA, Lopéz-Capitán C, González MB, Odero MD, San Miguel JF. 2003. Abnormalities on 1q and 7q are associated with poor outcome in sporadic Burkitt's lymphoma. A cytogenetic and comparative genomic hybridization study. Leukemia 17: 2016-2024.
16. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink H-K, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA. 1994. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84: 1361-1392.
17. Hummel M, Bentink S, Berger H, Klapper W, Wessendorf S, Barth TF, Bernd HW, Cogliatti SB, Dierlamm J, Feller AC, Hansmann ML, Haralambieva E, Harder L, Hasenclever D, Kühn M, Lenze D, Lichter P, Martin-Subero JI, Möller P, Müller-Hermelink HK, Ott G, Parwaresch RM, Pott C, Rosenwald A, Rosolowski M, Schwaenen C, Stürzenhofecker B, Szczepanowski M, Trautmann H, Wacker HH, Spang R, Loeffler M, Trümper L, Stein H, Siebert R. 2006. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med 354: 2419-2430.
18. Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, Qi Y, Scherer SW, Lee C. 2004. Detection of large-scale variation in the human genome. Nat Genet 36: 949-951.
19. Johansson B, Mertens F, Mitelman F. 1993. Cytogenetic deletion maps of hematologic neoplasms: Circumstantial evidence for tumor suppressor loci. Genes Chromosomes Cancer 8: 205-218.
20. Kaneko Y, Rowley JD, Variakojis D, Haren JM, Ueshima Y, Daly K, Kluskens LF. 1983. Prognostic implications of karyotype and morphology in patients with non-Hodgkin's lymphoma. Int J Cancer 32: 683-692.
21. Kawamata N, Ogawa S, Zimmermann M, Kato M, Sanada M, Hemminki K, Yamatomo G, Nannya Y, Koehler R, Flohr T, Miller CW, Harbott J, Ludwig W-D, Stanulla M, Schrappe M, Bartram CR, Koeffler HP. 2008. Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray. Blood 111: 776-784.
22. Kenkre VP, Stock W. 2009. Burkitt lymphoma/leukemia: Improving prognosis. Clin Lymphoma Myeloma 9: S231-S238.
23. Klapper W, Szczepanowski M, Burkhardt B, Berger H, Rosolowski M, Bentink S, Schwaenen C, Wessendorf S, Spang R, Möller P, Hansmann ML, Bernd HW, Ott G, Hummel M, Stein H, Loeffler M, Trümper L, Zimmermann M, Reiter A, Siebert R. 2008. Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials. Blood 112: 1374-1381.
24. Kornblau SM, Goodacre A, Cabanillas F. 1991. Chromosomal abnormalities in adult non-endemic Burkitt's lymphoma and leukemia: 22 New reports and a review of 148 cases from the literature. Hematol Oncol 9: 63-78.
25. Kuiper RP, Schoenmakers EFPM, van Reijmersdal SV, Hehir-Kwa JY, Geurts van Kessel A, van Leeuwen FN, Hoogerbrugge PM. 2007. High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression. Leukemia 21: 1258-1266.
26. Leoncini L, Raphaël M, Stein H, Harris NL, Jaffe ES, Kluin PM. 2008. Burkitt lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC, Pp. 262-264.
27. López-Corral L, Sarasquete ME, Beà S, García-Sanz R, Mateos MV, Corchete LA, García EM, Bladé J, Oriol A, Hernández-García MT, Giraldo P, Hernández J, González M, Hernández-Rivas JM, Miguel JS, Gutiérrez NC. SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma status. Leukemia (in press).
28. Lundin C, Hjorth L, Behrendtz M, Nordgren A, Palmqvist L, Andersen MK, Biloglav A, Forestier E, Paulsson K, Johansson B. 2011. High frequency of BTG1 deletions in acute lymphoblastic leukemia in children with Down syndrome. Genes Chromosomes Cancer 51: 196-206.
29. Magrath I. 2012. Epidemiology: Clues to the pathogenesis of Burkitt lymphoma. Br J Haematol 156: 744-756.
30. Magrath IT, Janus C, Edwards BK, Spiegel R, Jaffe ES, Berard CW, Miliauskas J, Morris K, Barnwell R. 1984. An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults. Blood 63: 1102-1111.
31. Malcolm S, Barton P, Murphy C, Ferguson-Smith MA, Bentley DL, Rabbitts TH. 1982. Localization of human immunoglobulin kappa light chain variable region genes to the short arm of chromosome 2 by in situ hybridization. Proc Natl Acad Sci U S A 79: 4957-4961.
32. Mitelman F, Andersson-Anvret M, Brandt L, Catovsky D, Klein G, Manolov G, Mark-Vendel E, Nilsson PG. 1979a. Reciprocal 8;14 translocation in EBV-negative B-cell acute lymphocytic leukemia with Burkitt-type cells. Int J Cancer 24: 27-33.
33. Mitelman F, Klein G, Andersson-Anvret M, Forsby N, Johansson B. 1979b. 14q+ Marker chromosome in an EBV-genome-negative lymph node without signs of malignancy in a patient with EBV-genome-positive nasopharyngeal carcinoma. Int J Cancer 23: 32-36.
34. Mitelman F, Johansson B, Mertens F. Mitelman database of chromosome aberrations and gene fusions in cancer. 2012. http://cgap.nci.nih.gov/Chromosomes/Mitelman.
35. Miyoshi I, Hiraki S, Kimura I, Miyamoto K, Sato J. 1979. 2/8 Translocation in a Japanese Burkitt's lymphoma. Experientia 35: 742-743.
36. Müller JR, Janz S, Goedert JJ, Potter M, Rabkin CS. 1995. Persistence of immunoglobulin heavy chain/c-myc recombination-positive lymphocyte clones in the blood of human immunodeficiency virus-infected homosexual men. Proc Natl Acad Sci U S A 92: 6577-6581.
37. Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD, Girtman K, Mathew S, Ma J, Pounds SB, Su X, Pui CH, Relling MV, Evans WE, Shurtleff SA, Downing JR. 2007. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446: 758-764.
38. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. 2005. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839-843.
39. Offit K, Parsa NZ, Gaidano G, Filippa DA, Louie D, Pan D, Jhanwar SC, Dalla-Favera R, Chaganti RS. 1993. 6q Deletions define distinct clinico-pathologic subsets of non-Hodgkin's lymphoma. Blood 82: 2157-2162.
40. Onciu M, Schlette E, Zhou Y, Raimondi SC, Giles FJ, Kantarjian HM, Medeiros LJ, Ribeiro RC, Pui CH, Sandlund JT. 2006. Secondary chromosomal abnormalities predict outcome in pediatric and adult high-stage Burkitt lymphoma. Cancer 107: 1084-1092.
41. Orem J, Mbidde EK, Lambert B, de Sanjose S, Weiderpass E. 2007. Burkitt's lymphoma in Africa, a review of the epidemiology and etiology. Afr Health Sci 7: 166-175.
42. Ota A, Tagawa H, Karnan S, Tsuzuki S, Karpas A, Kira S, Yoshida Y, Seto M. 2004. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res 64: 3087-3095.
43. Parsa NZ, Gaidano G, Mukherjee AB, Hauptschein RS, Lenoir G, Dalla-Favera R, Chaganti RS. 1994. Cytogenetic and molecular analysis of 6q deletions in Burkitt's lymphoma cell lines. Genes Chromosomes Cancer 9: 13-18.
44. Paulsson K, Cazier JB, Macdougall F, Stevens J, Stasevich I, Vrcelj N, Chaplin T, Lillington DM, Lister TA, Young BD. 2008. Microdeletions are a general feature of adult and adolescent acute lymphoblastic leukemia: Unexpected similarities with pediatric disease. Proc Natl Acad Sci U S A 105: 6708-6713.
45. Paulsson K, Forestier E, Lilljebjörn H, Heldrup J, Behrendtz M, Young BD, Johansson B. 2010. Genetic landscape of high hyperdiploid childhood acute lymphoblastic leukemia. Proc Natl Acad Sci U S A 107: 21719-21724.
46. Poirel HA, Cairo MS, Heerema NA, Swansbury J, Aupérin A, Launay E, Sanger WG, Talley P, Perkins SL, Raphaël M, McCarthy K, Sposto R, Gerrard M, Bernheim A, Patte C. 2009. Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: Results of the FAB/LMB 96 international study. Leukemia 23: 323-331.
47. Raghavan M, Smith LL, Lillington DM, Chaplin T, Kakkas I, Molloy G, Chelala C, Cazier JB, Cavenagh JD, Fitzgibbon J, Lister TA, Young BD. 2008. Segmental uniparental disomy is a commonly acquired genetic event in relapsed acute myeloid leukemia. Blood 112: 814-821.
48. Safavi S, Forestier E, Golovleva I, Barbany G, Nord KH, Moorman AV, Harrison CJ, Johansson B, Paulsson K. Loss of chromosomes is the primary event in near-haploid and low-hypodiploid acute lymphoblastic leukemia. Leukemia (in press).
49. Schiffman JD, Lorimer PD, Rodic V, Jahromi MS, Downie JM, Bayerl MG, Sanmann JN, Althof PA, Sanger WG, Barnette P, Perkins SL, Miles RR. 2011. Genome wide copy number analysis of paediatric Burkitt lymphoma using formalin-fixed tissues reveals a subset with gain of chromosome 13q and corresponding miRNA over expression. Br J Haematol 155: 477-486.
50. Scholtysik R, Kreuz M, Klapper W, Burkhardt B, Feller AC, Hummel M, Loeffler M, Rosolowski M, Schwaenen C, Spang R, Stein H, Thorns C, Trümper L, Vater I, Wessendorf S, Zenz T, Siebert R, Küppers R. 2010. Detection of genomic aberrations in molecularly defined Burkitt's lymphoma by array-based, high resolution, single nucleotide polymorphism analysis. Haematologica 95: 2047-2055.
51. Spender LC, Inman GJ. 2009. TGF-beta induces growth arrest in Burkitt lymphoma cells via transcriptional repression of E2F-1. J Biol Chem 284: 1435-1442.
52. Sylvestre Y, De Guire V, Querido E, Mukhopadhyay UK, Bourdeau V, Major F, Ferbeyre G, Chartrand P. 2007. An E2F/miR-20a autoregulatory feedback loop. J Biol Chem 282: 2135-2143.
53. Taub R, Kirsch I, Morton C, Lenoir G, Swan D, Tronick S, Aaronson S, Leder P. 1982. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc Natl Acad Sci U S A 79: 7837-7841.
54. Toujani S, Dessen P, Ithzar N, Danglot G, Richon C, Vassetzky Y, Robert T, Lazar V, Bosq J, Da Costa L, Pérot C, Ribrag V, Patte C, Wiels J, Bernheim A. 2009. High resolution genome-wide analysis of chromosomal alterations in Burkitt's lymphoma. PLoS One 4: e7089.
55. Van den Berghe H, Parloir C, Gosseye S, Englebienne V, Cornu G, Sokal G. 1979. Variant translocation in Burkitt lymphoma. Cancer Genet Cytogenet 1: 9-14.
56. H recombination events. J Mol Diagn 9: 47-54.
57. Yamamoto G, Nannya Y, Kato M, Sanada M, Levine RL, Kawamata N, Hangaishi A, Kurokawa M, Chiba S, Gilliland DG, Koeffler HP, Ogawa S. 2007. Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays. Am J Hum Genet 81: 114-126.
58. Zech L, Haglund U, Nilsson K, Klein G. 1976. Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas. Int J Cancer 17: 47-56.